- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cyclopharm Ltd (CYC)
Cyclopharm Ltd stock price live, this page displays ASX CYC stock exchange data. View the CYC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cyclopharm Ltd real time stock price chart below.
What Is the Cyclopharm Ltd Stock Price Today?
The Cyclopharm Ltd stock price today is 0.520.
What Is the Stock Symbol for Cyclopharm Ltd?
The stock symbol for Cyclopharm Ltd is "CYC."
What Stock Exchange Does Cyclopharm Ltd Trade On?
Cyclopharm Ltd is listed and trades on the Sydney stock exchange.
Is Cyclopharm Ltd a Good Stock to Buy?
Determining whether Cyclopharm Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYC quote. (ISIN: AU000000CYC5)
What Is the Cyclopharm Ltd Stock Price Today?
The Cyclopharm Ltd stock price today is 0.520.
What Is the Stock Symbol for Cyclopharm Ltd?
The stock symbol for Cyclopharm Ltd is "CYC."
What Stock Exchange Does Cyclopharm Ltd Trade On?
Cyclopharm Ltd is listed and trades on the Sydney stock exchange.
Is Cyclopharm Ltd a Good Stock to Buy?
Determining whether Cyclopharm Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYC quote. (ISIN: AU000000CYC5)
Sydney
Currency in AUD
0.520
+0.010(+1.96%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.520
0.530
52 wk Range
0.450
1.290
CYC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5200.530
52 wk Range
0.4501.290
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CYC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
0.995
Upside
+91.40%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.995
(+91.40% Upside)
Cyclopharm Ltd Earnings Call Summary for H1/2026
- Cyclopharm posted record H1 2026 revenue of AUD 17.5M, up 14% YoY, marking its fifth consecutive record half-year performance.
- Gross margin expanded to 56.3% from 53.5%, driven by higher-margin U.S. consumables; U.S. Technegas revenue surged 74% to AUD 2.1M.
- Net loss widened to AUD 8.8M from AUD 7.7M due to U.S. expansion investments; company raised AUD 13.5M, ending with AUD 12.2M cash.
- Management stated cash burn has peaked with no immediate capital raise planned; dividends may resume once U.S. operations become cash generative.
- New international guidelines named Technegas preferred ventilation agent; 83 U.S. sites live with 1,684 locations in active sales pipeline.
Last Updated: 2026-09-01, 09:42 p/m
Read Full TranscriptEarnings
Latest Release
Aug 23, 2026
EPS / Forecast
-0.07 / --
Revenue / Forecast
17.52M / --
Compare CYC to Peers and Sector
Metrics to compare | CYC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −1.7x | −0.4x | |
PEG Ratio | 0.11 | −0.06 | 0.00 | |
Price/Book | 2.1x | 2.7x | 2.6x | |
Price / LTM Sales | 1.9x | 1.9x | 3.1x | |
Upside (Analyst Target) | 91.3% | 152.4% | 48.9% | |
Fair Value Upside | Unlock | 16.0% | 6.8% | Unlock |
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cyclopharm Ltd (CYC) Stock Price Today?
The Cyclopharm Ltd stock price today is 0.520 AUD.
What Stock Exchange Does Cyclopharm Ltd Trade On?
Cyclopharm Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Cyclopharm Ltd?
The stock symbol for Cyclopharm Ltd is "CYC."
What Is the Cyclopharm Ltd Market Cap?
As of today, Cyclopharm Ltd market cap is 65.380M AUD.
What Is Cyclopharm Ltd's Earnings Per Share (TTM)?
The Cyclopharm Ltd EPS (TTM) is -0.160.
From a Technical Analysis Perspective, Is CYC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Cyclopharm Ltd Stock Split?
Cyclopharm Ltd has split 3 times.
How Many Employees Does Cyclopharm Ltd Have?
Cyclopharm Ltd has 104 employees.
What is the current trading status of Cyclopharm Ltd (CYC)?
As of Sep 06, 2026, Cyclopharm Ltd (CYC) is trading at a price of 0.520 AUD, with a previous close of 0.520 AUD. The stock has fluctuated within a day range of 0.520 AUD to 0.530 AUD, while its 52-week range spans from 0.450 AUD to 1.290 AUD.
What Is Cyclopharm Ltd (CYC) Price Target According to Analysts?
The average 12-month price target for Cyclopharm Ltd is 0.995 AUD, with a high estimate of 0.9952804 AUD and a low estimate of 0.9952804 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +91.40% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.